Belvedere Trading LLC Evelo Biosciences, Inc. Transaction History

Belvedere Trading LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 21, 2022	SELL	$1.46 - $3.55 $252,276 - $613,411	-172,792 Closed	0 $0
Q1 2022 Apr 20, 2022	SELL	$2.66 - $6.63 $181,797 - $453,127	-68,345 Reduced 28.34%	172,792 $397,000
Q4 2021 Jan 25, 2022	BUY	$6.07 - $12.0 $627,553 - $1.24 Million	103,386 Added 75.05%	241,137 $1.18 Million
Q3 2021 Oct 19, 2021	BUY	$6.79 - $13.9 $935,329 - $1.91 Million	137,751 New	137,751 $1.13 Million

Ticker EVLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,994,000
Description
Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hy...

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Belvedere Trading LLC with notifications on news.